Continuing its reputation as the world's best hospital for thyroid, parathyroid, and adrenal surgery, the Hospital for ...

Trial confirms elinzanetant's efficacy and safety in addressing vasomotor symptoms caused by adjuvant endocrine therapy in ...

In a review, a multitude of studies find women's reproductive health at risk with exposure to endocrine disrupting chemicals.

Explore the facts behind adrenal cocktails, their claimed benefits, potential risks, and why experts recommend focusing on ...

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

Hector Granados, one of two pediatric endocrinologists in El Paso, said he stopped providing gender-affirming care after it ...

Incredible” results from the PATINA trial suggested a new standard of care for HER2, ER-positive metastatic breast cancer.

The Center for Environmental Health (CEH), which is a nonprofit consumer advocacy group has highlighted that alarming levels ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Mersana shares Phase 1 data on Emi-Le for TNBC and details FDA's Fast Track status for XMT-1660 in advanced HER2-low breast ...

Substantial, Rapid and Sustained Statistically Significant Reductions of Key Biomarkers Achieved Across Doses, Including up to 80% Mean Reduction ...